What question did this study set out to answer?

To describe a rare adverse effect of furosemide, specifically xanthopsia, in a patient with liver cirrhosis.

May 20, 2026Open Access

Not Just Jaundice: Furosemide-Induced Yellow-Tinted Vision in Decompensated Liver Cirrhosis

Key Points

To describe a rare adverse effect of furosemide, specifically xanthopsia, in a patient with liver cirrhosis.
Case report of a 45-year-old man with alcohol-related cirrhosis
Xanthopsia developed following initiation of furosemide for ascites management
Symptoms resolved after discontinuing the medication
Patient experienced reversible xanthopsia after starting furosemide
Symptoms fully resolved upon stopping the drug
Highlights the need for monitoring visual symptoms in patients with liver dysfunction

Abstract

ABSTRACT Xanthopsia, a yellow-tinted visual disturbance, is a rarely reported adverse effect of furosemide. We present the case of a 45-year-old man with alcohol-related cirrhosis who developed reversible xanthopsia shortly after initiating furosemide for ascites management. Symptoms resolved on discontinuation of the drug. This case highlights a rare but important potential side effect of a commonly prescribed loop diuretic, particularly in patients with hepatic dysfunction, where altered pharmacokinetics may increase toxicity risk. Clinicians should maintain vigilance for visual symptoms when prescribing furosemide, especially in patients with renal and liver dysfunction.

Not Just Jaundice: Furosemide-Induced Yellow-Tinted Vision in Decompensated Liver Cirrhosis

Key Points

Abstract

Cite This Study

Also Consider

Also Consider